{"DataElement":{"publicId":"3320023","version":"1","preferredName":"Invasive Malignant Neoplasm Apocrine Feature Extent Status Category","preferredDefinition":"Text description and numeric percentage of the extent of the apocrine features associated with invasive cancer.","longName":"3319931v1.0:3319996v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3319931","version":"1","preferredName":"Invasive Malignant Neoplasm Apocrine Differentiation Extent","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_A morphologic finding that indicates the presence of cells with abundant eosinophilic and granular cytoplasm in a tumor sample._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","longName":"2206790v1.0:3319929v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206790","version":"1","preferredName":"Invasive Malignant Neoplasm","preferredDefinition":"marked by a tendency to spread especially into healthy tissue.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C14159:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0494-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3319929","version":"1","preferredName":"Apocrine Differentiation Extent","preferredDefinition":"No Value Exists:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","longName":"C62493:C25332","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Differentiation","conceptCode":"C62493","definition":"A morphologic finding that indicates the presence of cells with abundant eosinophilic and granular cytoplasm in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30DB66F-9444-28B4-E040-BB89AD435A64","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30DB66F-9455-28B4-E040-BB89AD435A64","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3319996","version":"1","preferredName":"Apocrine Feature Extent Status Category","preferredDefinition":"A morphologic finding that indicates the presence of cells with abundant eosinophilic and granular cytoplasm in a tumor sample._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._A condition or state at a particular time._Category; used informally to mean a class of things.","longName":"3319996v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"6","maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Marked (>50% of invasive carcinoma with apocrine features)","valueDescription":"Marked (>50% of invasive carcinoma with apocrine features)","ValueMeaning":{"publicId":"3319997","version":"1","preferredName":"Marked (>50% of invasive carcinoma with apocrine features)","longName":"3319997","preferredDefinition":"Marked (>50% of invasive carcinoma with apocrine features)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3104D5B-5FA2-57B6-E040-BB89AD437351","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3104D5B-5FBB-57B6-E040-BB89AD437351","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","deletedIndicator":"No"},{"value":"Moderate (6-50% of invasive carcinoma with apocrine features)","valueDescription":"Moderate (6-50% of invasive carcinoma with apocrine features)","ValueMeaning":{"publicId":"3319998","version":"1","preferredName":"Moderate (6-50% of invasive carcinoma with apocrine features)","longName":"3319998","preferredDefinition":"Moderate (6-50% of invasive carcinoma with apocrine features)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3104D5B-5FC5-57B6-E040-BB89AD437351","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3104D5B-5FDE-57B6-E040-BB89AD437351","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","deletedIndicator":"No"},{"value":"Minimal (1-5% of invasive carcinoma with apocrine features)","valueDescription":"Minimal (1-5% of invasive carcinoma with apocrine features)","ValueMeaning":{"publicId":"3319999","version":"1","preferredName":"Minimal (1-5% of invasive carcinoma with apocrine features)","longName":"3319999","preferredDefinition":"Minimal (1-5% of invasive carcinoma with apocrine features)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3104D5B-5FE8-57B6-E040-BB89AD437351","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3104D5B-6001-57B6-E040-BB89AD437351","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","deletedIndicator":"No"},{"value":"Absent","valueDescription":"Absent","ValueMeaning":{"publicId":"2566329","version":"1","preferredName":"Absent","longName":"2566329","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D026-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-05","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-08-05","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3104D5B-600B-57B6-E040-BB89AD437351","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3323686","version":"1","preferredName":"Apocrine Differentiation Extent Status Category","preferredDefinition":"A morphologic finding that indicates the presence of cells with abundant eosinophilic and granular cytoplasm in a tumor sample.:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.:A condition or state at a particular time.:Category; used informally to mean a class of things.","longName":"C62493:C25332:C25688:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Differentiation","conceptCode":"C62493","definition":"A morphologic finding that indicates the presence of cells with abundant eosinophilic and granular cytoplasm in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3765497-E99D-553B-E040-BB89AD433EAA","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3104D5B-5F8B-57B6-E040-BB89AD437351","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"COOPERM","dateModified":"2011-12-14","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Apocrine features","type":"Preferred Question Text","description":"Apocrine features","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31522DA-0945-29A0-E040-BB89AD430F30","latestVersionIndicator":"Yes","beginDate":"2011-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-01","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}